DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Beconase AQ (Beclomethasone Dipropionate Monohydrate) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

In general, side effects in clinical studies have been primarily associated with irritation of the nasal mucous membranes.

Adverse reactions reported in controlled clinical trials and open studies in patients treated with BECONASE AQ Nasal Spray are described below.

Mild nasopharyngeal irritation following the use of beclomethasone aqueous nasal spray has been reported in up to 24% of patients treated, including occasional sneezing attacks (about 4%) occurring immediately following use of the spray. In patients experiencing these symptoms, none had to discontinue treatment. The incidence of transient irritation and sneezing was approximately the same in the group of patients who received placebo in these studies, implying that these complaints may be related to vehicle components of the formulation.

Fewer than 5 per 100 patients reported headache, nausea, or lightheadedness following the use of BECONASE AQ Nasal Spray. Fewer than 3 per 100 patients reported nasal stuffiness, nosebleeds, rhinorrhea, or tearing eyes.

Rare cases of ulceration of the nasal mucosa and instances of nasal septum perforation have been spontaneously reported (see PRECAUTIONS).

Reports of dryness and irritation of the nose and throat and unpleasant taste and smell have been received. There are rare reports of loss of taste and smell.

Rare instances of wheezing, cataracts, glaucoma, and increased intraocular pressure have been reported following the use of intranasal beclomethasone dipropionate (see PRECAUTIONS).

Rare cases of immediate and delayed hypersensitivity reactions, including anaphylactoid/anaphylactic reactions, urticaria, angioedema, rash, and bronchospasm, have been reported following the oral and intranasal inhalation of beclomethasone dipropionate.

Cases of growth suppression have been reported for intranasal corticosteroids, including BECONASE AQ (see PRECAUTIONS: Pediatric Use).



REPORTS OF SUSPECTED BECONASE AQ SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Beconase AQ. The information is not vetted and should not be considered as verified clinical evidence.

Possible Beconase AQ side effects / adverse reactions in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient: 57 year old female

Reactions: Asthma, Cardiac Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Beconase AQ
    Dosage: 42mcg unknown
    Start date: 2009-01-12

Coreg
    Dosage: 2.5mg unknown

Fluticasone Propionate
    Start date: 2009-01-12

Ventolin
    Dosage: 90mcg unknown
    Start date: 2009-01-12



See index of all Beconase AQ side effect reports >>

Drug label data at the top of this Page last updated: 2013-06-29

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017